Academic Journal

Cureus

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Cureus has 1 tracked paper indexed in Blossom (2021) from 7 authors, most often covering Esketamine and Ketamine, across Depressive Disorders, Major Depressive Disorder (MDD) and Treatment-Resistant Depression (TRD).

Published Papers

Open Accessmeta

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review

This review (2021, s=10) finds that only one of three short-term studies found favourable effects of esketamine over only antidepressants for depression, but other studies did find longer time to relapse or a longer sustained improvement in depressive symptoms.

Published: August 21, 2021
Journal: Cureus
Authors: Sapkota, A., Khurshid, H., Qureshi, I. A., Jahan, N., Went, T. R., Sultan, W., Alfonso, M.

Quick Facts

Papers Indexed: 1
Publisher: Springer Nature
Website: Visit

Cureus

Research Footprint

Published Papers

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review

Quick Facts

Company

Product

Legal